Published in Imaging Med on April 01, 2012
Cholinergic dysfunction in Parkinson's disease. Curr Neurol Neurosci Rep (2013) 0.95
Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia. Continuum (Minneap Minn) (2016) 0.80
Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease. J Neurol (2016) 0.78
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
What we can do and what we cannot do with fMRI. Nature (2008) 9.82
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord (2008) 5.72
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology (2010) 4.06
The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology (2000) 3.98
Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology (2008) 3.68
Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol (2005) 3.31
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain (2009) 3.03
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol (2010) 2.69
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology (1997) 2.36
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology (2000) 2.27
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology (2009) 2.23
Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology (1996) 2.23
Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology (2006) 2.17
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry (2008) 2.12
Posterior cingulate cortex in Alzheimer's disease. Lancet (1994) 2.11
Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol (1983) 2.06
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain (2004) 2.06
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain (2011) 2.02
History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology (2009) 2.01
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol (2003) 1.94
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology (2010) 1.92
Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol (1983) 1.91
Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology (2005) 1.82
The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol (2008) 1.80
Dementia in Parkinson Disease. Ann Neurol (1979) 1.76
Striatal beta-amyloid deposition in Parkinson disease with dementia. J Neuropathol Exp Neurol (2008) 1.74
The morbid anatomy of dementia in Parkinson's disease. Acta Neuropathol (2009) 1.71
Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study. Neurobiol Dis (2007) 1.69
White matter hyperintensities and dynamics of postural control. Magn Reson Imaging (2009) 1.60
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology (2010) 1.58
Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med (2011) 1.54
Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord (2009) 1.54
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology (2005) 1.54
The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol (1995) 1.51
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci (1983) 1.51
Dysfunction of the default mode network in Parkinson disease: a functional magnetic resonance imaging study. Arch Neurol (2009) 1.49
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol (1996) 1.45
Cognitive impairments in advanced PD without dementia. Neurology (2002) 1.44
A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology (2000) 1.42
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol (2000) 1.41
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.39
Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. Neurobiol Dis (2008) 1.39
Parkinson's disease is associated with hippocampal atrophy. Mov Disord (2003) 1.37
Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol (1984) 1.34
Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol (2006) 1.34
An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol (1988) 1.33
Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study. Acta Neuropathol (2003) 1.29
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem (1992) 1.28
Amyloid imaging of Lewy body-associated disorders. Mov Disord (2010) 1.27
Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry (2004) 1.24
[11C]PIB binding in Parkinson's disease dementia. Neuroimage (2007) 1.24
A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging (2002) 1.19
Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol (2003) 1.15
The nucleus basalis of Meynert in neurological disease: a quantitative morphological study. Ann Neurol (1985) 1.15
Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord (2008) 1.15
Dopaminergic suppression of brain deactivation responses during sequence learning. J Neurosci (2008) 1.15
White matter lesions and disequilibrium in older people. I. Case-control comparison. Arch Neurol (1995) 1.14
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain (1992) 1.13
Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol (2005) 1.07
Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med (2011) 1.06
Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology. Parkinsonism Relat Disord (2007) 1.05
Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia? Acta Neuropathol (2009) 1.05
Dopamine modulates default mode network deactivation in elderly individuals during the Tower of London task. Neurosci Lett (2009) 1.04
Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm (Vienna) (2001) 1.03
Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain (2005) 1.02
Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol Aging (2005) 1.02
Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov Disord (2005) 1.01
Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease. Brain Res (1986) 1.00
Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Ann Neurol (1999) 1.00
Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR Am J Neuroradiol (1995) 1.00
Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol (2007) 0.99
Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol (1998) 0.99
Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. Am J Geriatr Psychiatry (2006) 0.99
Cholinergic deficiency and frontal dysfunction in Parkinson's disease. Ann Neurol (1990) 0.99
Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord (2006) 0.98
Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain (2011) 0.98
Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord (2005) 0.97
Cholinergic-dependent cognitive deficits in Parkinson's disease. Ann Neurol (1987) 0.96
A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur J Neurol (2007) 0.96
Dementia and Parkinson's disease. Br J Psychiatry (1989) 0.95
Dementia in Parkinson's disease: diffusion tensor imaging. Acta Neurol Scand (2007) 0.95
Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol Aging (2007) 0.94
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med (1997) 0.94
Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia. Alzheimers Dement (2008) 0.94
Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Dis Assoc Disord (2010) 0.93
Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology (1988) 0.93
The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease. Neurol Neurochir Pol (2009) 0.92
Development and evaluation of iodinated tracers targeting amyloid plaques for SPECT imaging. J Mol Neurosci (2004) 0.91
Alzheimer disease and the dementia of Parkinson disease: comparative investigations. Alzheimer Dis Assoc Disord (1990) 0.90
Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study. Parkinsonism Relat Disord (2008) 0.89
In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med (1994) 0.89
Clinico-pathological correlations in Parkinson's disease. Clin Neurol Neurosurg (1992) 0.89
Usefulness of diffusion tensor imaging of white matter in Alzheimer disease and vascular dementia. Acta Radiol (2004) 0.89
SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry (1992) 0.89
Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology (2013) 3.56
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain (2010) 2.37
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. J Nucl Med (2013) 1.93
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement (2013) 1.87
β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Mov Disord (2012) 1.69
Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology (2014) 1.59
Altered resting state cortico-striatal connectivity in mild to moderate stage Parkinson's disease. Front Syst Neurosci (2010) 1.41
Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. J Cereb Blood Flow Metab (2012) 1.32
Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol (2012) 1.14
Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain (2013) 1.12
[18F]FDOPA PET and clinical features in parkinsonism due to manganism. Mov Disord (2005) 1.11
Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics (2014) 1.05
Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology (2012) 1.04
Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease. J Neurophysiol (2009) 1.04
In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. J Nucl Med (2014) 1.04
Spared caudal brainstem SERT binding in early Parkinson's disease. J Cereb Blood Flow Metab (2007) 1.02
Cholinergic denervation occurs early in Parkinson disease. Neurology (2009) 0.98
Cerebral small vessel disease and incident parkinsonism: the RUN DMC study. Neurology (2016) 0.96
Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord (2013) 0.96
Cholinergic dysfunction in Parkinson's disease. Curr Neurol Neurosci Rep (2013) 0.95
Striatal dopamine denervation and sensory integration for balance in middle-aged and older adults. Gait Posture (2006) 0.94
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. J Nucl Med (2013) 0.89
Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Mov Disord (2014) 0.89
Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults. J Clin Neurosci (2011) 0.87
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging. Alzheimers Dement (2013) 0.85
Rhinorrhea: a common nondopaminergic feature of Parkinson's disease. Mov Disord (2010) 0.85
Dopamine overdose hypothesis: evidence and clinical implications. Mov Disord (2013) 0.85
Clinical markers for identifying cholinergic deficits in Parkinson's disease. Mov Disord (2014) 0.84
Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities. J Clin Sleep Med (2013) 0.84
l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease. Behav Brain Res (2012) 0.84
Gender differences in cholinergic and dopaminergic deficits in Parkinson disease. J Neural Transm (Vienna) (2013) 0.82
FDG-PET and molecular brain imaging in the movement disorders clinic. Neurology (2012) 0.82
Cognitive correlates of brain MRI subcortical signal hyperintensities in non-demented elderly. Int J Geriatr Psychiatry (2006) 0.82
Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders. Neurosci Lett (2012) 0.81
Olfactory loss and nigrostriatal dopaminergic denervation in the elderly. Neurosci Lett (2010) 0.81
The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease. Behav Brain Res (2013) 0.81
Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity. Parkinsonism Relat Disord (2009) 0.80
The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. PLoS One (2012) 0.80
Source memory and frontal functioning in Parkinson's disease. J Int Neuropsychol Soc (2009) 0.80
Single case study of brain FDG PET imaging in a patient with catatonia. Clin Nucl Med (2013) 0.80
Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET. Radiology (2012) 0.79
Age-related striatal dopaminergic denervation and severity of a slip perturbation. J Gerontol A Biol Sci Med Sci (2011) 0.78
Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease. Arch Neurol (2012) 0.78
Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease. J Gerontol A Biol Sci Med Sci (2014) 0.78
Effects of donepezil on compulsive hypersexual behavior in Parkinson disease: a single case study. Am J Ther (2005) 0.76
A 26-year-old woman with recurrent loss of consciousness. J Gen Intern Med (2011) 0.75
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis? Neurology (2012) 0.75
Author response. Neurology (2014) 0.75
Clinical features of Parkinson disease when onset of diabetes came first: a case-control study. Neurology (2012) 0.75
Autoimmune limbic encephalitis detected on FDG brain scan performed for the evaluation of dementia. Clin Nucl Med (2015) 0.75
A frontotemporal dementia-like syndrome mimicking postpartum depression detected by 18F fluorodeoxyglucose positron emission tomography. Clin Nucl Med (2012) 0.75
2014 SNMMI Highlights Lecture: Neuroscience. J Nucl Med (2014) 0.75